Huang Dennis Karl 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Huang Dennis Karl
See Remarks
Transactions
- Award
Common Stock
2022-03-01+14,000→ 51,040 total - Award
Stock Option (Right to Buy)
2022-03-01+24,900→ 24,900 totalExercise: $67.37Exp: 2032-03-01→ Common Stock (24,900 underlying) - Sale
Common Stock
2022-03-01$66.62/sh−3,234$215,449→ 36,914 total
Footnotes (5)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
- [F2]Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
- [F3]Includes 126 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021.
- [F4]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F5]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.